Technoclone Gets FDA Marketing Authorization for ADAMTS13 Activity Test
The Technozym ADAMTS13 Activity assay is an ELISA intended for the qualitative determination of ADAMTS13 activity.
Read MorePosted by Andy Lundin | Mar 5, 2024 | Hematology & Serology |
The Technozym ADAMTS13 Activity assay is an ELISA intended for the qualitative determination of ADAMTS13 activity.
Read MorePosted by Chris Wolski | Feb 22, 2024 | Calibrators, Controls |
The CLP January/February 2024 Tech Guide that appears in CLP features a wide-range of products from top laboratory providers.
Read MorePosted by Chris Wolski | Feb 14, 2024 | Immunoassay |
The January/February 2024 Tech Guide that appears in CLP features a wide-range of products from top laboratory providers.
Read MorePosted by Andy Lundin | Feb 6, 2024 | Molecular Diagnostics |
Researchers developed a system that allows for same-day analysis of genetic mutations to get results faster, and easier than current methods.
Read MorePosted by Andy Lundin | Jan 31, 2024 | Cancer, Hematology & Serology |
Agilent will expand its CDx portfolio with novel biomarkers and Incyte will leverage Agilent’s expertise in IVD assay development.
Read More